FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096459 [Registered on: 24/10/2025] Trial Registered Prospectively
Last Modified On: 26/04/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical study to evaluate the effect of sarvanga tvagadi alepa in the management of amavata w.s.r to rheumatoid arthritis  
Scientific Title of Study   A randomised controlled clinical study to evaluate the effect of sarvanga tvagadi alepa in the management of amavata w.s.r to rheumatoid arthritis  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sushmitha K  
Designation  Pg Scholar  
Affiliation  shri dharmasthala manjunatheshwara college of ayurveda hospital and research centre kuthpady udupi 
Address  OPD-9 department of panchakarma shri dharmasthala manjunatheshwara college of ayurveda hospital and research centre kuthpady udupi

Udupi
KARNATAKA
574118
India 
Phone  8921691070  
Fax    
Email  sushmithakgg@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Padmakiran C 
Designation  BAMS MD(AYU) Ph.D Professor department of panchakarma  
Affiliation  shri dharmasthala manjunatheshwara college of ayurveda hospital and research centre kuthpady udupi 
Address  OPD-9 Department of panchakarma shri dharmasthala manjunatheshwara college of ayurveda hospital and research centre kuthpady udupi

Udupi
KARNATAKA
574118
India 
Phone  9448953038  
Fax    
Email  kiranasdm@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Padmakiran C 
Designation  BAMS MD(AYU) Ph.D PROFESSOR DEPARTMENT OF PANCHAKARMA 
Affiliation  shri dharmasthala manjunatheshwara college of ayurveda hospital and research centre kuthpady udupi 
Address  OPD-9 department of panchakarma shri dharmasthala manjunatheshwara college of ayurveda hospital and research centre kuthpady udupi

Udupi
KARNATAKA
574118
India 
Phone  9448953038  
Fax    
Email  kiranasdm@gmail.com  
 
Source of Monetary or Material Support  
shri dharmasthala manjunatheshwara ayurveda pharmacy Kuthpady Udupi karnataka india-574118 
 
Primary Sponsor  
Name  Sushmitha K  
Address  Nethravathi ladies hostel near Sdm college of Ayurveda Kuthpady Udupi 574118 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sushmitha K   Shri Dharmasthala Manjunatheshwara College of Ayurveda Hospital and Research centre kuthpady Udupi  OPD-9 department of panchakarma udupi karnataka
Udupi
KARNATAKA 
8921691070

sushmithakgg@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Shri Dharmasthala Manjunatheshwara College of Ayurveda Udupi Institutional Ethical clearance committee-humans  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M059||Rheumatoid arthritis with rheumatoid factor, unspecified. Ayurveda Condition: AMAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: sarvanga tvagadi alepa, Reference: NA, Route: Topical, Dosage Form: Lepa Churna, Dose: 400(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator Arm (Non Ayurveda)-agni chikitsa alepaAgnichikitsa alepa: Lashuna – 8 beads, Lavanga – 8 in number, Maricha – 8 seeds, Sarshapa – 5gm, Haridra – 5gm these are the 5 dry drugs and wet drugs are Vanatulasi, Kshudra agnimantha, Nirgundi, Papata, Bandha. Leaves of these wet drugs taken in equal quantity sufficient enough to prepare a paste to apply all over the body of the patient. These leaves should be washed and the thick mid veins present in the leaves should be removed and chopped into small pieces. Then dry drugs and wet drugs are mixed together and grinded into a smooth semisolid paste by adding required quantity of water.
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients fulfilling diagnostic criteria.
Patients who are fit for Alepa chikitsa.
 
 
ExclusionCriteria 
Details  All connective tissue disorders other than Rheumatoid arthritis.
Patients with any other systemic illness which will hamper treatment.
All patients who are allergic to alepa.
 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Parametric data analysed before and after the study using paired t test for within the group and unpaired t test for between the group.
Non parametric data analysed before and after the study using Wilcoxon signed rank test for within the group and Mann Whitney test for between the group.
The signs and symptoms will be assessed before treatment on 0th day and after the treatment on 7th day and after 14 days of follow up based on subjective and objective parameters.  
14 days 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   • This is an open label comparative clinical study with pre-test and post-test design where minimum 30 patients of Amavata of either gender will be selected based on diagnostic and inclusion criteria and randomly distributed between Agnichikitsa alepa and Sarvanga Tvagadi alepa group.   
Close